1. Pink Sheet

Dostarlimab, Zynteglo & COVID-19 Combo Drugs In The Spotlight At EMA

 
• By Neena Brizmohun

The sponsors of seven new drugs are set to find out this week whether the European Medicines Agency’s human medicines committee, the CHMP, will recommend pan-EU approval for their products. CHMP action is also expected regarding two potential combination therapies for COVID-19.

COVID-19
Scientific opinions are due on the use of two combination treatments for COVID-19 in the EU • Source: Shutterstock

GlaxoSmithKline should soon learn whether it has successfully addressed the issues that prevented the European Medicines Agency from adopting an opinion last month on whether or not its investigational endometrial cancer treatment, dostarlimab, should be granted marketing approval.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography